人脱细胞真皮增加乳房重建手术部位感染与总体并发症风险:更新荟萃分析
该更新荟萃分析纳入2012年后新研究及新产品,比较人脱细胞真皮基质(HADM)辅助与胸肌下乳房重建的并发症风险。结果显示HADM组总体并发症、皮瓣坏死和感染风险显著增加,而血清肿、血肿和假体取出无显著差异。结论提示需权衡HADM的美学优势与感染及皮瓣坏死风险。
要点
- HADM辅助乳房重建总体并发症风险显著高于胸肌下重建(RR=1.46)。
- HADM组皮瓣坏死风险显著增加(RR=2.39),感染风险亦显著增加(RR=1.5)。
- 血清肿、血肿和假体取出在两组间无显著差异。
核心结论
- HADM辅助组织扩张器/假体乳房重建较胸肌下 placement 增加总体并发症、感染和皮瓣坏死风险。
- 需权衡HADM在改善美学效果、增加术中填充量和缓解包膜挛缩方面的优势。
主要发现
- HADM组总体并发症发生率17.7%,对照组6.1%。
- HADM组血清肿8.3% vs 5.4%,感染7.2% vs 5.9%,皮瓣坏死14.7% vs 7.1%。
关键数值与推荐
- 总体并发症:HADM组17.7% vs 对照组6.1%。
- 皮瓣坏死:HADM组14.7% vs 对照组7.1%。
- 感染:HADM组7.2% vs 对照组5.9%。
- 血清肿、血肿和假体取出两组间无显著差异。
临床怎么用
- 临床决策时应告知患者HADM辅助重建可能增加感染和皮瓣坏死风险。
- 需结合患者个体情况权衡HADM的美学与功能优势及并发症风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Human acellular dermal matrix (HADM) is an increasingly used adjunct to breast reconstruction. Previous meta-analyses demonstrate increased risks of complications, but these studies largely represent one product. The purpose of this study is to stratify outcomes on the basis of a meta-analysis of complications incorporating all new studies after 2012 and their associated new human-based products. METHODS: A query of the MEDLINE database for articles on HADM and breast reconstruction from January 2012 to October 2015 yielded 172 citations. Two levels of screening identified 47 relevant studies. Thirteen studies were used in comparative meta-analysis. RESULTS: Complication rates were higher in HADM patients: total complications, 17.7% versus 6.1%; seroma, 8.3% versus 5.4%; infection, 7.2% versus 5.9%; and flap necrosis, 14.7% versus 7.1%. Meta-analysis revealed a statistically significant increased risk of total complications in patients who underwent reconstruction with HADM when compared with their submuscular reconstruction cohort (p = 0.03; relative risk (RR) = 1.46; confidence interval (CI): 1.04-2.04). Patients who underwent reconstruction with HADM demonstrated a significantly increased risk of flap necrosis (p < 0.01; RR = 2.39; CI: 1.8-3.16) and infection (p = 0.02; RR = 1.5; CI: 1.07-2.09) when compared with those who underwent submuscular reconstruction. There was no significant difference in seroma, hematoma, or implant explantation between these two groups. CONCLUSIONS: This study suggests an increased risk of overall complications, specifically infection and flap necrosis, in patients who underwent tissue expander/implant breast reconstruction with HADM when compared with those who underwent submuscular placement. This must be weighed against the advantages in enhancing aesthetic outcomes, increasing intraoperative fill volume, and ameliorating capsular contracture.
引用
- Smith JM, Broyles JM, Guo Y, et al. Human acellular dermis increases surgical site infection and overall complication profile when compared with submuscular breast reconstruction: An updated meta-analysis incorporating new products✰. J Plast Reconstr Aesthet Surg. 2018. PMID: 30093286. doi:10.1016/j.bjps.2018.06.012
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。